EPSRC - Centre for Innovative Manufacturing in Regenerative Medicine

News and updates

UK-US collaboration with Harvard Stem Cell Institute produces new manufacturing chapter for StemBook

May
08

stembook

A new UK-US collaboration between the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine and the Harvard Stem Cell Institute has resulted in a chapter focusing on regenerative medicine manufacturing tools and technologies being created within StemBook, an open access collection of reference materials aimed at both stem cell and non-specialist researchers.

The new manufacturing chapter can be found here, with the first paper published within the chapter being entitled ‘Regulatory challenges for the manufacture and scale-out of autologous cell therapies‘. This paper is authored by Dr Paul Hourd, Dr Amit Chandra, Prof Nick Medcalf and Prof David Williams, all of Loughborough University and the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine.

Additional manufacturing-themed papers are in the final stages of preparation, and we will announce these as they are added. A number of these papers are being prepared by academic and commercial members of the national community managed by the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine. Prof David Williams has recently joined the editorial board for StemBook.

Dr Sophie Dale-Black, Head of Engagement for the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine, said: “We are delighted to announce our collaboration with the Harvard Stem Cell Institute in co-creating a manufacturing-themed chapter for StemBook. We believe that this will be a very useful resource for scientists and engineers working in our field. Our engagement with Harvard will be further developed this summer with Elizabeth Cheeseman taking part in Harvard’s internship programme. These opportunities have come about following a US road trip by leading academics in the UK that was organised with support from the Science and Innovation Network.”

The new manufacturing chapter can be viewed here.

The new paper ‘Regulatory challenges for the manufacture and scale-out of autologous cell therapies’ can be viewed here.

 

About StemBook

Stem Book is an open access collection of invited, original, peer-reviewed chapters covering a range of topics related to stem cell biology written by top researchers in the field at the Harvard Stem Cell Institute and worldwide. Stem Book is aimed at stem cell and non-specialist researchers.